¼¼°èÀÇ ½ºÇÇÄ¡ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå
Speech Biomarkers
»óǰÄÚµå : 1757866
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 283 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,053,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ½ºÇÇÄ¡ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº 2030³â±îÁö 13¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 5¾ï 7,610¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ½ºÇÇÄ¡ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 14.7%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 13¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Á֯ļö´Â CAGR 14.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 4¾ï 8,260¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÁøÆø ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 13.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 5,700¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 19.5%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½ºÇÇÄ¡ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº 2024³â¿¡ 1¾ï 5,700¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 19.5%·Î 2030³â±îÁö 2¾ï 8,190¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 10.9%¿Í 13.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 11.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ½ºÇÇÄ¡ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

À½¼º ¹ÙÀÌ¿À¸¶Ä¿°¡ µðÁöÅÐ °Ç°­, ½Å°æ ÅðÇ༺ Áúȯ °¨Áö, °³ÀÎÈ­ ¸ð´ÏÅ͸µ¿¡¼­ Àü·«Àû Á߿伺À» °®´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

À½¼º ¹ÙÀÌ¿À¸¶Ä¿´Â ¹ß¼º ÆÐÅÏ, À½Çâ ½ÅÈ£, ¾ð¾î »ç¿ëÀ» ÅëÇØ ´Ù¾çÇÑ ÀÇÇÐÀû, ½É¸®Àû »óŸ¦ °¨ÁöÇÏ°í ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀû, ½Ç½Ã°£ ºñħ½ÀÀû ¹æ¹ýÀ¸·Î ºü¸£°Ô ºÎ»óÇϰí ÀÖ½À´Ï´Ù. À½¼º ±â·Ï¿¡¼­ ÃßÃâÇÑ ÀÌ·¯ÇÑ ¹ÙÀÌ¿À¸¶Ä¿´Â ½Å°æÁúȯ, Á¤½Å°Ç°­ »óÅÂ, ÀÎÁö ±â´É ÀúÇÏÀÇ Ãʱâ ¡Èĸ¦ ½Äº°ÇÏ´Â µ¥ »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀÓ»ó Áø´Ü°ú Àå±âÀûÀΠȯÀÚ ¸ð´ÏÅ͸µ ¸ðµÎ¿¡ ¸Å¿ì À¯¿ëÇÕ´Ï´Ù. ÇコÄɾ ¿¹¹æ, ¿ø°Ý, °³ÀÎÈ­ ¸ðµ¨·Î ÀüȯÇÏ´Â °¡¿îµ¥, À½¼º ¹ÙÀÌ¿À¸¶Ä¿´Â µðÁöÅÐ Çコ »ýŰ迡 È®Àå °¡´ÉÇÏ°í »ç¿ëÇϱ⠽¬¿î ÅøÀ» Á¦°øÇÕ´Ï´Ù.

¾ËÃ÷ÇÏÀ̸Ӻ´, ÆÄŲ½¼º´, ¿ì¿ïÁõ, ºÒ¾ÈÀå¾Ö, ±âŸ ÀÎÁö ¹× ±âºÐÀå¾ÖÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ħ½ÀÀûÀÎ °Ë»ç³ª ÁÖ°üÀûÀÎ º¸°í¿¡ ÀÇÁ¸ÇÏÁö ¾Ê´Â ¼öµ¿ÀûÀ̰í Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. À½¼º ¹ÙÀÌ¿À¸¶Ä¿´Â ½º¸¶Æ®Æù, ¿ø°ÝÀÇ·á Ç÷§Æû, ¿þ¾î·¯ºí ±â±â¸¦ ÅëÇÑ Á¶±â °³ÀÔ, Ä¡·á ÃÖÀûÈ­, ½ÇÁ¦ °Ç°­ ÃßÀûÀ» °¡´ÉÇÏ°Ô ÇÏ´Â Â÷¼¼´ë Áø´Ü¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

AI ¾Ë°í¸®Áò, ¾ð¾î ¸ðµ¨¸µ, À½Ç⠺м®Àº ¾î¶»°Ô À½¼º ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ½Ç¿ë¼ºÀ» ³ôÀ̰í Àִ°¡?

À½¼º ¹ÙÀÌ¿À¸¶Ä¿ °³¹ßÀÇ ÇÙ½ÉÀº ÇÇÄ¡, À½»ö, Åæ, ¸®µë, ¸Á¼³ÀÓ, ¿îÀ², ±¸À½, ¾îÈÖ ±¸Á¶¿Í °°Àº À½¼º ¸Å°³º¯¼ö¸¦ ºÐ¼®ÇÏ´Â °í±Þ ¸Ó½Å·¯´× ¹× ½Åȣó¸® ¾Ë°í¸®Áò¿¡ ÀÖ½À´Ï´Ù. ÀÚ¿¬ ¾ð¾î ó¸®(NLP)´Â ÀǹÌÀÇ Àϰü¼º, ±¸¹®ÀÇ º¹À⼺, Á¤¼­Àû °¨Á¤À» Æò°¡ÇÏ´Â µ¥ »ç¿ëµÇ¸ç, Á¤½Å »óÅÂ¿Í ÀÎÁö ±â´É¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

AI ±â¹Ý ¸ðµ¨Àº ´ë±Ô¸ðÀÇ ´Ù¾çÇÑ À½¼º µ¥ÀÌÅͼ¼Æ®·Î ÈÆ·ÃµÇ¾î Áõ»óÀÌ ³ªÅ¸³ª±â Àü¿¡µµ Áúº´ ƯÀ¯ÀÇ ¹ß¼º ÆÐÅÏÀ» ÀνÄÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¸ðµ¨Àº ´õ ³ôÀº ¹Î°¨µµ, ¾ð¾î °£ Àû¿ë¼º, Àα¸Åë°èÇÐÀû Á߸³¼ºÀ» À§ÇØ Áö¼ÓÀûÀ¸·Î °³¼±µÇ°í ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ¾Û, ½º¸¶Æ® ½ºÇÇÄ¿, µðÁöÅÐ Ä¡·á Ç÷§Æû°úÀÇ ÅëÇÕÀ» ÅëÇØ À½¼º ±â¹Ý Æò°¡´Â ¼Ò±Ô¸ð·Î ´ë±Ô¸ð·Î ¹èÆ÷ÇÒ ¼ö ÀÖ½À´Ï´Ù.

À½¼º°ú Ç¥Á¤, ¿òÁ÷ÀÓ, »ý¸®Àû µ¥ÀÌÅ͸¦ °áÇÕÇÑ ¸ÖƼ¸ð´Þ ½Ã½ºÅÛµµ ƯÈ÷ Á¤½Å½Å°æ Æò°¡, ¸¸¼ºÁúȯ °ü¸® µîÀÇ Áø´Ü Á¤È®µµ¸¦ ³ôÀ̱â À§ÇØ °³¹ßµÇ°í ÀÖ½À´Ï´Ù.

½ºÇÇÄ¡ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ´Â ÀÓ»ó ¹× »ó¾÷ ºÐ¾ß´Â?

ÇコÄÉ¾î ¹× »ý¸í°úÇÐÀº ƯÈ÷ ½Å°æÇÐ, Á¤½ÅÀÇÇÐ, ³ë³âÇп¡¼­ À½¼º ¹ÙÀÌ¿À¸¶Ä¿¸¦ äÅÃÇÏ´Â ÁÖ¿ä ºÐ¾ßÀÔ´Ï´Ù. ÀÓ»ó½ÃÇè¿¡¼­´Â ȯÀÚ °èÃþÈ­, µðÁöÅÐ ¿£µåÆ÷ÀÎÆ®, ¿ø°Ý À¯È¿¼º ¸ð´ÏÅ͸µ¿¡ À½¼º ¹ÙÀÌ¿À¸¶Ä¿°¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹ß¼ºÀÇ Æ¯Â¡ÀÌ Áúº´ÀÇ ÁøÇàÀ̳ª Ä¡·á È¿°ú¸¦ ¹Ý¿µÇÒ ¼ö ÀÖ´Â ¼øÈ¯±â³»°ú³ª È£Èí±â³»°ú¿¡¼­ÀÇ »ç¿ëµµ °ËÅäµÇ°í ÀÖ½À´Ï´Ù.

µðÁöÅÐ Çコ ½ºÅ¸Æ®¾÷, Á¦¾à»ç, ¿ø°ÝÀÇ·á Ç÷§Æû¿¡¼­ À½¼ºÀÎ½Ä ¹ÙÀÌ¿À¸¶Ä¿ÀÇ »ó¾÷Àû Ȱ¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. À½¼º Áö¿ø ¾Û°ú AI ±â¹Ý °¡»ó ºñ¼­°¡ À½¼º ¹ÙÀÌ¿À¸¶Ä¿¸¦ Ȱ¿ëÇÏ¿© ¼±º°°Ë»ç, Á¶±â °ËÁø, Çൿ °Ç°­ °ü·Ã ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. º¸Çè»ç¿Í °í¿ëÁÖµéÀº Àû±ØÀûÀÎ °Ç°­ ÁõÁø ÇÁ·Î±×·¥ÀÇ ÀÏȯÀ¸·Î À½¼º ±â¹Ý À£´Ï½º Æ®·¡Å·À» °í·ÁÇϱ⠽ÃÀÛÇß½À´Ï´Ù.

ºÏ¹Ì¿Í À¯·´Àº źźÇÑ µðÁöÅÐ Çコ »ýŰè, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ±ÔÁ¦, º¥Ã³Ä³ÇÇÅÐÀÇ ÀÚ±Ý Áö¿øÀ» ¹ÙÅÁÀ¸·Î ¿¬±¸°³¹ß°ú ÀÓ»ó °ËÁõÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¸ð¹ÙÀÏ Çコ ÀÎÇÁ¶óÀÇ È®´ë¿Í Àα¸ ±Ô¸ð¿¡ µû¸¥ °ËÁø ±¸»ó¿¡ ÈûÀÔ¾î ¼ºÀå Áö¿ªÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

½ºÇÇÄ¡ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

½ºÇÇÄ¡ ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº ÇコÄÉ¾î ½Ã½ºÅÛÀÌ ºñ¿ë È¿À²ÀûÀ̰í, È®Àå °¡´ÉÇϸç, ¿ø°ÝÁö¿¡¼­µµ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ´Â Áø´Ü ÅøÀ» ¿ä±¸ÇÔ¿¡ µû¶ó ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ÙÀÌ¿À¸¶Ä¿´Â Áúº´ÀÇ Á¶±â ¹ß°ß, ¸ÂÃãÇü ÀÇ·á, Áö¼ÓÀûÀÎ °Ç°­ ¸ð´ÏÅ͸µ°ú °°Àº Áß¿äÇÑ ¿ä±¸¿¡ ºÎÀÀÇÏ°í ´ë¸é Æò°¡ ¹× ħ½ÀÀû °Ë»ç¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â ½Å°æ ¹× Á¤½Å ÁúȯÀÇ ºÎ´ã Áõ°¡, À½¼º ºÐ¼® AIÀÇ ¹ßÀü, ºÐ»êÇü ÀÓ»ó½ÃÇè¿¡ ´ëÇÑ ¼ö¿ä, À½¼º ±â¹Ý ±â¼ú¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ½Å·Úµµ Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ½º¸¶Æ®Æù, ¿þ¾î·¯ºí, µðÁöÅÐ Ä¡·áÁ¦¿ÍÀÇ ÅëÇÕÀº Á¢±Ù¼º°ú ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁý ±â´ÉÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

À½¼ºÀÌ »ç¶÷ÀÇ °Ç°­À» ¾Ë ¼ö Àִ â±¸°¡ µÊ¿¡ µû¶ó À½¼º ¹ÙÀÌ¿À¸¶Ä¿´Â ÀÏ»óÀûÀÎ ´ëÈ­¸¦ ÀÇÇÐÀû ÀλçÀÌÆ®¿Í Á¶±â °³ÀÔÀ» À§ÇÑ °­·ÂÇÑ Åø·Î ÀüȯÇÏ¿© ÀÓ»ó Áø´ÜÀ» ÀçÁ¤ÀÇÇÒ ¼ö Àִ°¡?

ºÎ¹®

À¯Çü(Á֯ļö, ÁøÆø, ¿¡·¯À², ¹ßÀ½ ½Ã°£); ¾ÖÇø®ÄÉÀ̼Ç(Á¤½Å Àå¾Ö, È£Èí ºÎÀü, ±âŸ ¾ÖÇø®ÄÉÀ̼Ç)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 43»ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Speech Biomarkers Market to Reach US$1.3 Billion by 2030

The global market for Speech Biomarkers estimated at US$576.1 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2024-2030. Frequency, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$482.6 Million by the end of the analysis period. Growth in the Amplitude segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$157.0 Million While China is Forecast to Grow at 19.5% CAGR

The Speech Biomarkers market in the U.S. is estimated at US$157.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$281.9 Million by the year 2030 trailing a CAGR of 19.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.9% and 13.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.7% CAGR.

Global Speech Biomarkers Market - Key Trends & Drivers Summarized

Why Are Speech Biomarkers Gaining Strategic Importance in Digital Health, Neurodegenerative Disease Detection, and Personalized Monitoring?

Speech biomarkers are rapidly emerging as a non-invasive, real-time method to detect and monitor a wide range of medical and psychological conditions through vocal patterns, acoustic signals, and language use. These biomarkers-extracted from voice recordings-are being used to identify early signs of neurological disorders, mental health conditions, and cognitive decline, making them highly valuable for both clinical diagnosis and longitudinal patient monitoring. As healthcare moves toward preventive, remote, and personalized models, speech biomarkers offer a scalable and accessible tool for digital health ecosystems.

The rising prevalence of Alzheimer’s, Parkinson’s, depression, anxiety, and other cognitive or mood disorders is accelerating demand for passive, continuous monitoring tools that do not rely on invasive testing or subjective reporting. Speech biomarkers are becoming integral to next-generation diagnostics, enabling early intervention, treatment optimization, and real-world health tracking via smartphones, telehealth platforms, and wearable devices.

How Are AI Algorithms, Linguistic Modeling, and Acoustic Analysis Advancing the Utility of Speech Biomarkers?

The core of speech biomarker development lies in advanced machine learning and signal processing algorithms that analyze speech parameters such as pitch, tone, rhythm, hesitation, prosody, articulation, and vocabulary structure. Natural language processing (NLP) is used to assess semantic coherence, syntactic complexity, and emotional sentiment-providing insight into mental states and cognitive function.

AI-powered models are trained on large, diverse speech datasets to recognize disease-specific vocal patterns, even before overt symptoms appear. These models are being continuously refined for greater sensitivity, cross-language applicability, and demographic neutrality. Integration with mobile apps, smart speakers, and digital therapeutic platforms is making it possible to deploy speech-based assessments unobtrusively, at scale.

Multimodal systems combining voice with facial expression, movement, or physiological data are also being developed to enhance diagnostic precision, especially in neuropsychiatric evaluation and chronic disease management.

Which Clinical and Commercial Sectors Are Driving the Adoption of Speech Biomarkers?

Healthcare and life sciences are the primary domains for speech biomarker adoption, particularly in neurology, psychiatry, and geriatrics. Clinical trials are leveraging speech biomarkers for patient stratification, digital endpoints, and remote efficacy monitoring. Speech is also being explored for use in cardiology and respiratory care, where vocal features may reflect disease progression or treatment response.

Commercial deployment is growing among digital health startups, pharmaceutical companies, and telemedicine platforms. Voice-enabled apps and AI-powered virtual health assistants are incorporating speech biomarkers for triage, early screening, and behavioral health insights. Insurance providers and employers are beginning to explore speech-based wellness tracking as part of proactive health programs.

North America and Europe lead in R&D and clinical validation, supported by robust digital health ecosystems, data privacy regulations, and venture capital funding. Asia-Pacific is emerging as a growth region due to expanding mobile health infrastructure and population-scale screening initiatives.

What Are the Factors Driving Growth in the Speech Biomarkers Market?

The speech biomarkers market is expanding rapidly as healthcare systems seek cost-effective, scalable, and remote-friendly diagnostic tools. These biomarkers address critical needs in early disease detection, personalized medicine, and continuous health monitoring-all while reducing reliance on in-person evaluations and invasive testing.

Key growth drivers include increasing burden of neurological and mental health disorders, advancement in voice analysis AI, demand for decentralized clinical trials, and rising consumer comfort with voice-based technologies. Integration into smartphones, wearables, and digital therapeutics is further enhancing accessibility and real-time data capture capabilities.

As voice becomes a window into human health, could speech biomarkers redefine clinical diagnostics by transforming everyday conversation into a powerful tool for medical insight and early intervention?

SCOPE OF STUDY:

The report analyzes the Speech Biomarkers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Frequency, Amplitude, Error Rate, Pronunciation Time); Application (Mental Disorder, Respiratory Failure, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â